Y08060
Y08060 is a selective BET inhibitor. Y08060 inhibits the viability of C4-2B and LNCaP cell lines with IC50 values of 3.23 and 4.41 μM. Y08060 can suppress colony formation as well as AR expression in prostate cancer cell line. Y08060 can be studied in prostate cancer research[1].
Product Specifications
CAS Number
2222565-19-5
UNSPSC
12352005
Target
Epigenetic Reader Domain
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1NC2=CC(OC)=C(NS(=O)(C3=CC(Br)=CC=C3OC)=O)C=C2OC1(C)C
Molecular Formula
C18H19BrN2O6S
Molecular Weight
471.32
References & Citations
[1]Xiang, Q., et al., (2018) . Y08060: A Selective BET Inhibitor for Treatment of Prostate Cancer. ACS medicinal chemistry letters, 9 (3), 262-267.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470304-100 1x 100 µL
CD106 / VCAM1 (B-K9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470669-500 1x 500 µL
P27 / KIP1 (SX53G8), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-500 1x 500 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 